Ro, J., Park, S., Kim, S. B., Kim, T. Y., Im, Y. H., Rha, S. Y., . . . Santillana, S. (2012). Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: An open-label expanded access study in Korea. BioMed Central.
Citación estilo ChicagoRo, Jungsil, Sohee Park, Sung- Bae Kim, Tae You Kim, Young Hyuk Im, Sun Young Rha, Joo Seop Chung, Hanlim Moon, y Sergio Santillana. Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Brain Metastasis Treated With Lapatinib and Capecitabine: An Open-label Expanded Access Study in Korea. BioMed Central, 2012.
Cita MLARo, Jungsil, et al. Clinical Outcomes of HER2-positive Metastatic Breast Cancer Patients With Brain Metastasis Treated With Lapatinib and Capecitabine: An Open-label Expanded Access Study in Korea. BioMed Central, 2012.